Literature DB >> 11979548

Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.

Krzysztof Mrózek1, Kristiina Heinonen, Karl S Theil, Clara D Bloomfield.   

Abstract

We used spectral karyotyping (SKY) to study 29 adults with acute myeloid leukemia and a complex karyotype containing one to nine abnormalities that were not fully identifiable by G-banding. SKY showed the origin of rings and unidentified material in unbalanced translocations in all cases and the origin of markers in most, allowing reinterpretation of 136 aberrations and discovery of three aberrations hidden in normal chromosomes. SKY confirmed 10 and refined the interpretation of three balanced aberrations recognized by G-banding and identified another nine balanced aberrations, including a novel translocation involving the RUNX1 gene. Eleven of 32 deletions found by G-banding were shown to be cryptic translocations or insertions, including three of four chromosome 3 deletions, two of three del(7q), and two of 12 del(5q). Of the 92 chromosomes deemed lost entirely by G-banding, 63 (68%) were shown to be involved in structural aberrations. This was especially true for -21 (eight of eight patients), -5 (five of six patients), -20 (seven of nine patients), and -18 (six of 12 patients). Unexpectedly, SKY uncovered a hidden overrepresentation of segments from at least one chromosome in 21 patients. The most frequently overrepresented was 21q, found in eight patients, including four with high-level 21q amplification. Fluorescence in situ hybridization showed that the RUNX1 gene was not the target of amplification in seven of these patients. Also frequently gained were 11q (in seven patients, including three with high-level MLL gene amplification) and 22q (in seven patients). We conclude that SKY considerably enhances the accuracy of karyotype interpretation, and that amplification of chromosomal material may play a greater role in leukemogenesis than has been recognized. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11979548     DOI: 10.1002/gcc.10027

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

1.  Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma.

Authors:  Shanthi Sivendran; Stephen Gruenstein; Adriana K Malone; Vesna Najfeld
Journal:  J Hematol Oncol       Date:  2010-07-22       Impact factor: 17.388

Review 2.  Spectral karyotyping: an unique technique for the detection of complex genomic rearrangements in leukemia.

Authors:  Bo Guo; Xiaoping Han; Zhanhe Wu; Wanming Da; Hongli Zhu
Journal:  Transl Pediatr       Date:  2014-04

Review 3.  Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.

Authors:  Krzysztof Mrózek
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

Review 4.  Molecular cytogenetics in haematological malignancy: current technology and future prospects.

Authors:  Lyndal Kearney; Sharon W Horsley
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

5.  Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics.

Authors:  David Wald; Johanna M Vermaat; Gil Peleg; William Tse
Journal:  Curr Hematol Malig Rep       Date:  2008-04       Impact factor: 3.952

Review 6.  Cytogenetics in acute myeloid leukemia.

Authors:  Claudia Schoch; Torsten Haferlach
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

7.  New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.

Authors:  Alison Walker; Krzysztof Mrózek; Jessica Kohlschmidt; Kathleen W Rao; Mark J Pettenati; Lisa J Sterling; Guido Marcucci; Andrew J Carroll; Clara D Bloomfield
Journal:  Genes Chromosomes Cancer       Date:  2012-12-10       Impact factor: 5.006

Review 8.  Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.

Authors:  Tara K Gregory; David Wald; Yichu Chen; Johanna M Vermaat; Yin Xiong; William Tse
Journal:  J Hematol Oncol       Date:  2009-06-02       Impact factor: 17.388

9.  Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

Authors:  Claudia D Baldus; Sandya Liyanarachchi; Krzysztof Mrózek; Herbert Auer; Stephan M Tanner; Martin Guimond; Amy S Ruppert; Nehad Mohamed; Ramana V Davuluri; Michael A Caligiuri; Clara D Bloomfield; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

Review 10.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.